Search
Filters
Clear All
  • 15
  • 52
  • 2
  • 647

Phase

  • 1
  • 11
  • 14
  • 47
  • 7
  • 66
  • 6
  • 541
  • 654
  • 299

Found 716 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Study of UX701 Gene Transfer for the Treatment of Wilson Disease

C
Craig Lammert, MD
18 years and older
All genders
Phase 1/2
Interventional
The primary objectives of this study are to evaluate the safety of single IV doses of UX701with Wilson disease, to select the UX701 dose with the best benefit/risk profile based on the totality of safety and efficacy data and to evaluate the effect of UX701 ongulation.
Learn More

Ruptured Aneurysms Treated With Hydrogel Coils (RAGE)

B
Bradley N. Bohnstedt, MD
18-80 years
All genders
Observational
To determine safety and occlusion rates when second-generation hydrogel coils are used in theuptured intracranial aneurysms.
Learn More

Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV

N
Naga Chalasani, MD
18-80 years
All genders
Observational
Nonalcoholic fatty liver disease (NAFLD) is a spectrum of liver conditions associated withumulation that ranges from benign, non-progressive liver fat accumulation to severever injury, cirrhosis, and liver failure. NAFLD is the most common liver disease in USdults and the second leading cause for liver transplantation in the US. The natural …
Learn More

The Merit WRAPSODY AV Access Efficacy Study (WAVE) (WAVE)

T
Thomas Casciani, MD
18 years and older
All genders
Interventional
The purpose of the study is to demonstrate the safety and efficacy of the Merit WRAPSODYdovascular Stent Graft for treatment of stenosis or occlusion within the dialysis accessutflow circuit
Learn More

A Prospective and Retrospective, Multi-Centre, Post-Market, Non-Interventional Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches (PANTHER)

J
Joel Corvera, MD
18 years and older
All genders
Observational
The purpose of this registry is to collect safety and performance data on all commerciallyvailable Terumo Aortic knitted and woven grafts, and cardiovascular patches in standard. Data will be collected both retrospectively and prospectively.
Learn More

Academic-Community EPINET (AC-EPINET) (AC-EPINET)

A
Alan Breier, MD
16-35 years
All genders
Interventional
The investigators propose to examine the effects of CSC services delivered via TH (CSC-TH) versus the standard clinic-based CSC model (CSC-SD) on engagement and outcomes in a 12-month,domized trial.
Learn More

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) (POPS or POP02)

G
Gregory Sokol, MD
20 years and younger
Accepts healthy volunteer
All genders
The study investigators are interested in learning more about how drugs, that are given tohildren by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of thisudy is to evaluate the …
Learn More

Improving the Quality of Care for Adults With Inflammatory Bowel Disease (IBD:QORUS)

S
Sashidhar Sagi, MD
18 years and older
All genders
Observational
Innovative programs exist that suggest that care for people with chronic conditions iszed when patients and providers have the information they need at the point of care andver time, to engage in shared planning and execution of treatment goals and care plans. Thisject aims to build an Inflammatory Bowel Disease …
Learn More

TrialNet Pathway to Prevention of T1D

L
Linda DiMeglio, MD
30-45 years
Accepts healthy volunteer
All genders
RationaleThe accrual of data from the laboratory and from epidemiologic and prevention trials hasved the understanding of the etiology and pathogenesis of type 1 diabetes mellitus (T1DM). Genetic and immunologic factors play a key role in the development of T1DM, andharacterization of the early metabolic abnormalities in T1DM is steadily …
Learn More

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

S
Sandeep Batra, MD
21 years and younger
All genders
Phase 3
Interventional
This phase III trial compares standard chemotherapy to therapy with liposome-encapsulated daunorubicin-cytarabine (CPX-351) and/or gilteritinib for patients with newly diagnosed acuteyeloid leukemia with or without FLT3 mutations. Drugs used in chemotherapy, such as daunorubicin, cytarabine, and gemtuzumab ozogamicin, work in different ways to stop the growth of cancer cells, either …
Learn More
621 - 630 of 716